Richard Maurice Walmsley
Fondateur chez Gentronix Ltd.
Postes actifs de Richard Maurice Walmsley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Gentronix Ltd.
 Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/01/1999 | - |
| Fondateur | 22/03/2010 | - | |
| University of Manchester Institute of Science & Technology | Corporate Officer/Principal | - | - |
Historique de carrière de Richard Maurice Walmsley
Formation de Richard Maurice Walmsley
| University of Kent | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Gentronix Ltd.
Gentronix Ltd. BiotechnologyHealth Technology Gentronix Ltd. provides services and solutions to help organizations optimize the development of drugs and other chemicals. It provides contract services for genotoxicity using a patented human cell GADD45a reporter GreenScreen HC and BlueScreen HC assays and related assays including Micronucleus and Ames MPF. The company was founded by Richard Maurice Walmsley in July 1999 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Richard Maurice Walmsley
- Expérience
